Related by context. All words. (Click for frequent words.) 63 outcome 59 Outcomes 58 perinatal outcomes 57 measurable outcomes 56 adverse perinatal 55 neurodevelopmental outcomes 55 Outcome 55 HRQL 53 oncologic outcomes 53 postoperative mortality 53 neurologic outcomes 53 radiographic outcomes 52 guideline concordant 52 interventions 52 Hill Rom enhancing 51 QoL 51 graft patency 51 nonpharmacologic 51 HRQOL 51 postoperative radiotherapy 51 poststroke depression 50 antioxidant supplementation 50 everolimus eluting stents 50 predictive validity 50 morbidity mortality 50 prognostic indicators 50 neurodevelopmental outcome 50 Socioeconomic status 50 perinatal mortality 50 prognostic variables 50 bronchopulmonary dysplasia BPD 49 cerebral somatic oximeter 49 angiographic outcomes 49 HRQoL 49 oral anticoagulant therapy 49 longitudinal cohort 49 postoperative pulmonary 49 tumor histology 49 results 49 HORIZONS AMI trial 49 psychosocial functioning 49 pathogenetic mechanisms 49 SCD HeFT 48 Roxana Mehran MD 48 psychosocial variables 48 nonoperative treatment 48 CPAP adherence 48 macrovascular events 48 immunosuppressive regimens 48 clinical endpoints 48 Randomized trials 48 morbidity 48 meta regression 48 HCAHPS scores 48 intracranial stenosis 48 atherosclerotic renal artery stenosis 48 KRAS status 48 virologic responses 48 QoF 48 perinatal morbidity 48 MMSE scores 48 symptomatic VTE 48 adjuvant therapies 48 events ADEs 48 CINQUIL 48 perfusion abnormalities 48 IMPROVE HF 47 CYP#D# genotype 47 subthreshold depression 47 platelet reactivity 47 meta analytic 47 DLQI 47 postdischarge 47 MHQP 47 methodologically sound 47 Baseline characteristics 47 PNH patients 47 dyslipidaemia 47 generalisable 47 ski lls 47 thrombotic complications 47 mortality morbidity 47 resynchronization therapy 47 non pharmacological interventions 47 Meta analyzes 47 haemodynamic 47 perioperative complications 47 Observational studies 47 HQID project 47 clinically localized prostate 47 patient subpopulations 47 quantifiable metrics 47 prognostic factors 47 nonoperative 47 SYNTAX 47 socioeconomic status SES 47 liver histology 47 recurrent miscarriage 47 perioperative mortality 47 Predictive modeling 47 HIV HCV coinfected 47 VTE prophylaxis 47 tumor subtype 47 atherothrombotic 47 demographic subgroups 47 coronary revascularization 46 likelihoods 46 pharmacologic treatments 46 neurocognitive function 46 TF CBT 46 Afib 46 nomograms 46 confounder 46 abnormal glucose tolerance 46 PITX2 methylation 46 PCWP 46 pharmacological therapies 46 perioperative morbidity 46 Outcomes Framework 46 readmission rates 46 pharmacological interventions 46 prognostically 46 SYNTAX trial 46 clinically meaningful reductions 46 glycemic control 46 carotid IMT 46 VADT 46 Logistic regression 46 cystinosis patients 46 APOE genotype 46 underlying pathophysiology 46 ELBW infants 46 avoidable hospitalizations 46 DVT PE 46 KIF6 carriers 46 postoperative complication 46 Subgroup analyzes 46 comorbidities 46 androgen depletion 46 Randomized clinical trials 46 Symptom severity 46 pharmacogenetic tests 46 lipid profiles 46 multivariate analyzes 46 stratifying patients 46 inflammatory biomarkers 46 HbA1C levels 46 stepwise logistic regression 46 myocardial viability 46 antibiotic regimens 46 GIK infusion 46 rEEG 46 CORE OM 46 preoperative diagnosis 46 hemodynamics 46 paclitaxel eluting stents 46 EDEMA3 trial 46 explanatory variables 46 nephron sparing surgery 46 AF ablation 46 incomplete revascularization 46 thromboprophylaxis 46 dose statin therapy 46 pharmacodynamic parameters 46 subclinical atherosclerosis 46 pharmacological therapy 46 Dr. Kallmes 46 ADEs 46 persistency mortality 46 randomized controlled trials RCTs 46 MDRD 46 behavioral interventions 46 somatic symptoms 46 unmeasured factors 46 exploratory endpoints 46 postoperative chemotherapy 46 HQID 45 ambulatory settings 45 CARE HF 45 spontaneous vaginal 45 neonatal morbidity 45 sociodemographic factors 45 Prognostic factors 45 metabolic abnormalities 45 maternal morbidity 45 esophagogastric 45 subgroup analyzes 45 morbidities 45 Logistic regression analysis 45 comorbid disorders 45 facial transplantation 45 obstructive CAD 45 dietary interventions 45 assigning probabilities 45 aetiology 45 rehospitalization 45 Multiple logistic regression 45 urodynamic parameters 45 tissue perfusion 45 venous thromboembolic disease 45 venous thromboembolism prophylaxis 45 coronary interventions 45 EGFR mutation status 45 antiangiogenic therapy 45 sustained virological response 45 ethnic disparities 45 Comparative effectiveness 45 neurobehavioral functioning 45 QTc intervals 45 immunological responses 45 micronutrient supplementation 45 fragility fractures 45 angiographically 45 causal pathways 45 platelet inhibition 45 Archimedes Model 45 antenatal depression 45 logistic regression models 45 serum clusterin levels 45 readmissions 45 immunosuppression therapy 45 arterial revascularization 45 adenotonsillectomy 45 antibiotic prophylaxis 45 virological response 45 pharmacokinetic interaction 45 oncological outcomes 45 interrater reliability 45 ICD therapy 45 cerebral oxygenation 45 symptomatic carotid stenosis 45 HbA 1C 45 noncardiac chest pain 45 Longitudinal studies 45 atherosclerotic coronary 45 perinatal complications 45 OnDose TM 45 EDSS scores 45 postoperative infections 45 R0 resection 45 patient centeredness 45 EPPIC 45 pre operatively 45 renal scarring 45 colonoscopic 45 riociguat 45 thoracoscopic lobectomy 45 limb salvage 45 postsurgical 45 elective cesarean delivery 45 atherosclerosis regression 45 DESs 45 conditional logistic regression 45 cervical lymph nodes 45 parkinsonian symptoms 45 nonfasting triglyceride levels 45 postoperative morbidity 45 authors conclude 45 antiphospholipid syndrome 45 postoperative atrial fibrillation 45 myocardial function 45 Apgar scores 45 chemosensitivity 45 secondary efficacy endpoints 45 echocardiographic parameters 45 psychosocial distress 44 perioperatively 44 peri procedural 44 CVD mortality 44 NIHSS score 44 ConclusionThis 44 thromboembolic complications 44 HYVET 44 warfarin dosing 44 periprocedural MI 44 methotrexate monotherapy 44 nutrient supplementation 44 Recurrence Score 44 cardiopulmonary diseases 44 Dr. Marc Gillinov 44 preoperative intraoperative 44 medication adherence 44 Oncotype DX Recurrence Score 44 rehospitalizations 44 PM#.# exposure 44 comorbid depression 44 hsCRP levels 44 preventing premature births 44 glycemia 44 lipoprotein profiles 44 analgesic efficacy 44 narrow QRS 44 multicenter trials 44 Minimally invasive surgery 44 noncancer 44 dosimetric 44 prognostic markers 44 Bergenstal 44 recanalization 44 glycemic variability 44 cognitive behavioral therapies 44 Stent thrombosis 44 Treatment Outcomes 44 psychiatric morbidity 44 tele ICU 44 meta analytic review 44 Cognitive behavioral 44 Outpatient Setting 44 pathophysiologic mechanisms 44 neuropsychological impairments 44 EuroSCORE 44 LAGB 44 CRT ICD 44 individualize therapy 44 hemorrhagic complications 44 CHD mortality 44 ragweed allergic 44 MTWA testing 44 periprocedural 44 pharmacoeconomic 44 NLX P# 44 Coronary Artery Bypass Graft 44 glial tumors 44 carotid angioplasty 44 overdiagnose 44 Charlson comorbidity index 44 Comorbidities 44 psychotherapies 44 cardiometabolic risk 44 dose atorvastatin 44 nodal metastases 44 peri natal 44 adjuvant radiation 44 cerebral perfusion 44 tumor resection 44 convergent validity 44 logistic regression analysis 44 STRIDE PD 44 depressive symptom 44 sociodemographic variables 44 atherothrombotic disease 44 ischemic cardiomyopathy 44 atherogenic dyslipidemia 44 postoperative AF 44 inhaled nitric oxide 44 tissue oxygenation 44 HF hospitalization 44 virologic response 44 glycosylated hemoglobin levels 44 locoregional 44 prospectively stratified 44 clinically meaningful improvements 44 pulmonary dysfunction 44 metabolic parameters 44 ICD implantation 44 Treatment Outcome 44 chronic LBP 44 HAQ DI 44 methodologic 44 spinal metastases 44 inhospital 44 comorbid illnesses 44 DAS# scores 44 curability 44 decubitus ulcers 44 behaviors 44 SIMPADICO 44 psychosocial stressors 44 sternal wound infections 44 cosmesis 44 mRS 44 pathophysiological mechanisms 44 androgen deprivation 44 BMI z 44 BEXXAR Therapeutic Regimen 44 unmeasured confounding 44 baseline HbA1c 44 psychiatric comorbidity 44 comorbid diagnoses 44 coronary stenoses 44 revascularization procedures 44 multivariate regression 44 ventricular tachyarrhythmia 44 neurocognitive deficits 44 catheter angiography 44 unnecessary hospitalizations 44 logistic regression analyzes 44 histological subtypes 43 psychotherapeutic interventions 43 Outcomes Framework QOF 43 observational cohort 43 Cardiorespiratory fitness 43 liver metastasis 43 psychiatric comorbidities 43 interobserver 43 nonfatal MI 43 contralateral breast cancer 43 immune reconstitution syndrome 43 Renal Cell Carcinoma RCC 43 renal tumors 43 carotid stenosis 43 Project SCIP 43 balanced scorecards 43 erection hardness 43 certain inheritable diseases 43 events MACE 43 A1c levels 43 Multivariate logistic regression 43 unresectable tumors 43 sonographic diagnosis 43 cognitive affective 43 generalisability 43 socioeconomic status 43 reflux symptoms 43 co morbidities 43 non squamous histology 43 decompensated cirrhosis 43 MitraClip device 43 hematologic malignancy 43 PROactive study 43 MDRD equation 43 adverse cytogenetics 43 intracerebral haemorrhage 43 hyperbilirubinemia 43 ER CHOP 43 Pulmonary rehabilitation 43 Darzi review 43 Descriptive statistics 43 Educational attainment 43 coronary anatomy 43 noncardiovascular mortality 43 Y BOCS 43 recurrent venous thromboembolism 43 suicide attempters 43 antiplatelet therapies 43 distributional impacts 43 therapeutic regimens 43 GP Consortia 43 ICD shocks 43 Coronary CT angiography 43 Dialysis Outcomes 43 ACCORD Lipid 43 AMOR IPAT 43 empirically validated 43 prespecified secondary 43 adolescent idiopathic scoliosis 43 HIV tropism 43 hemodynamic parameters 43 HSMR 43 CLABSIs 43 predictors 43 chemoembolization 43 chemoradiotherapy 43 CAM modalities 43 chorioamnionitis 43 transcatheter aortic valve implantation 43 patients undergoing CABG 43 Genetic variants 43 hemoglobin A1c levels 43 pharmacological approaches 43 antithrombotic therapy 43 percutaneous cryoablation 43 androgen suppression 43 NNT = 43 QIDS SR 43 differential gene expression 43 testosterone supplementation 43 CaPre TM 43 SLNB 43 prostate carcinogenesis 43 interindividual variability 43 prospective longitudinal 43 Zevalin consolidation 43 hypofractionated radiation 43 HCAHPS 43 sociodemographic characteristics 43 microvascular complications 43 comorbid conditions 43 QOF indicators 43 inhospital mortality 43 vaginal progesterone gel 43 undergoing liver transplantation 43 uncontrolled asthma 43 Depressive symptoms 43 TAXUS VI 43 ENDEAVOR clinical 43 risk stratification 43 CT angiograms 43 waist circumference WC 43 HbA 1c levels 43 Personality traits 43 RE LY ® 43 brainwave patterns 43 QALYs 43 depressive symptoms 43 methodologically rigorous 43 PbR 43 PSQI 43 pharmacokinetic characteristics 43 ICD CRT 43 Primary endpoints 43 antipsychotic prescribing 43 CABG 43 intra abdominal abscess 43 psychodynamic psychotherapy 43 fibrotic disease 43 cervical cerclage 43 Surgical Outcomes 43 microvascular disease 43 viral kinetics 43 intravascular hemolysis 43 Coronary artery calcium 43 familial clustering 43 PROMs 43 thromboembolic disease 43 prospective multicenter study 43 hemodynamic measurements 43 cardiac autonomic 43 arterial thickening 43 Formative assessment 43 lipid levels 43 nonpharmacological 43 STEMI patients 43 coronary CTA 43 atherothrombosis 43 poorer prognosis 43 vascular endothelial dysfunction 43 percutaneous coronary interventions 43 prenatally diagnosed 43 discriminant 43 subscale scores 43 lung resection 43 Dr Pesce 43 racial disproportionality 43 BEXXAR therapeutic regimen 43 epidural steroid injection 43 renal flares 43 refractory angina 43 MEDai Pinpoint Review www.medai.com 43 chemotherapeutic doxorubicin 43 varespladib 43 sirolimus eluting stents 43 ALSFRS R 43 CYPHER ® 43 randomized trials 43 pulmonary capillary wedge 43 developmental trajectories 43 p = .# [002] 43 cranial irradiation 43 embolic stroke 43 atherosclerotic disease 43 hypertension diabetes mellitus 43 QTinno TM 43 GWTG 43 oral anticoagulation 43 Endothelial function 43 neurocognitive functioning 43 prospective observational studies 43 Cystic Fibrosis Questionnaire Revised 43 unnecessary readmissions 43 Montgomery Asberg Depression 43 CMHCs 43 prospective multicentre 43 multivariate regression analysis 43 NICE SUGAR 43 CHADS 43 Better Outcomes 43 PSADT 43 CLBP 43 Mitochondrial diseases 43 prostate cancer CaP 43 RE LY 43 sonographic findings 43 chronic periodontitis 43 OpenNotes 43 palliation 43 zinc supplementation 43 preoperatively 43 regression equations 43 cesarean births 43 serum cotinine levels 43 cardiovascular morbidity 43 antibiotic prescribing 43 Sensitivity specificity 43 interpersonal psychotherapy 43 histologically proven 43 anticoagulation therapy 43 clinicians 43 pneumococcal carriage 43 cortical stimulation 43 nonadherence 43 measurable 43 Randomised controlled trials 43 Richard Gliklich MD 42 PROLARIS 42 hormone receptor status 42 summative assessments 42 blinded randomized controlled 42 antiplatelet therapy 42 fundholding 42 retransplantation 42 immunologic responses 42 angina myocardial infarction 42 anticoagulation clinics 42 Coronary artery bypass graft 42 extracolonic findings 42 Multiple linear regression 42 ejaculatory function 42 extracapsular extension 42 VLBW 42 electrophysiologic 42 ADCS CGIC 42 cardio metabolic 42 intact parathyroid hormone 42 pharmacogenetic testing 42 Kidney Disease Outcomes 42 Comorbidity 42 arteriovenous fistulas 42 surgeries Deyo 42 ALI ARDS 42 RUGs IV 42 pathophysiological processes 42 biomedically 42 Suicidal ideation 42 anthropometric measures 42 CYPHER R Sirolimus eluting 42 extrapyramidal symptoms 42 Reputational risk 42 ipsilateral stroke 42 cerebrovascular events 42 carotid stenting 42 nocebo effect 42 EMPOWER TM 42 comorbidity 42 Venous stasis ulcers 42 epidural analgesia 42 vesicoureteral reflux 42 cognitive domains 42 dyssynchrony 42 genetic determinants 42 geriatric syndromes 42 myocardial reperfusion 42 convenient dosing regimen 42 Laura Mauri 42 ClairVia Demand Manager 42 ADAS cog 42 revascularization 42 Coronary artery bypass grafting 42 bivariate analyzes 42 secondary efficacy endpoint 42 emotional dysregulation 42 retinal thickness 42 FFR guided 42 mitochondrial defects 42 stem cell transplantations 42 surrogate endpoint 42 glycated hemoglobin levels 42 intima media thickness 42 treating neuropathic pain 42 lipid parameters 42 chronicity 42 developmental neurotoxicity 42 mitral regurgitation MR 42 Complication rates 42 Todd Braver 42 medication nonadherence 42 hematological parameters 42 death reinfarction 42 cervical myelopathy 42 histological subtype 42 β blockers 42 Exacerbations 42 nondepressed 42 pharmacological intervention 42 coronary revascularizations 42 untreated OSA 42 MACCE 42 Radical prostatectomy 42 postsurgical complications 42 maladaptive behaviors 42 biologic pathways 42 Dr. Puliafito 42 bowel resection 42 coronary revascularization procedures 42 intraobserver 42 MUHC ensuring 42 hypertensive disorders 42 serum lipid levels 42 neoadjuvant 42 univariate analyzes 42 FDG-PET/CT 42 neuropsychiatric diseases 42 uncontrolled epilepsy 42 pulmonary toxicity 42 sustained virologic response 42 Zemplar Capsules 42 symptom flare ups 42 osteoporotic compression fractures 42 HbA1c levels 42 lupus renal disease 42 preoperative chemotherapy 42 assign probabilities 42 premium IOLs 42 radiographic findings 42 etiologic 42 biochemical recurrence 42 bioprosthetic valve 42 Change PGIC 42 elective percutaneous coronary 42 HORIZONS AMI 42 Preoperatively 42 Liver biopsy 42 graft occlusion 42 occlusive vascular 42 cluster randomized controlled 42 nocturnal hypoglycaemia 42 efficacy 42 MGuard ™ 42 potentially modifiable 42 fetal malformations 42 perfusion CT 42 Frobell 42 haematologic 42 Vascugel ® 42 ATACAND 42 prognostic indicator 42 adjuvant chemotherapy 42 posttransplant 42 Dr. Cliby 42 Univariate analysis 42 catheter ablations 42 TVAAS 42 allele frequencies 42 Edwards SAPIEN valve 42 pCR 42 Post operatively 42 endothelin antagonists 42 symptomatic intracerebral hemorrhage 42 macroeconomic variables 42 bivariate 42 atherosclerotic progression 42 liver resection 42 surrogate markers 42 PGD PGS 42 distributional effects 42 sentinel lymph node biopsy 42 platelet function 42 recurrent myocardial infarction 42 carotid artery narrowing 42 certolizumab 42 NEVO RES 42 neuromotor 42 ulcer healing 42 intrapartum 42 efficacious therapies 42 debulking surgery 42 Kras mutation 42 pharmacologic intervention 42 cystectomy 42 SGRQ 42 interventional cardiac 42 pharmacoeconomics 42 PROactive 42 antireflux surgery 42 onset AF 42 preterm infant 42 prescribers pharmacists 42 neuropsychological assessments 42 depressive symptomatology 42 Non inferiority 42 OncotypeDX 42 Regression analyzes 42 Boden Albala 42 RCTs 42 surgical debulking 42 YMRS 42 percutaneous intervention 42 glycoprotein IIb IIIa inhibitors 42 virologic suppression 42 sleeve lobectomy 42 Systematic reviews 42 endovascular interventions 42 inflammatory rheumatic 42 body habitus 42 Viral load 42 Neuropsychiatric Inventory 42 untreated psychosis 42 TTF Therapy 42 serum markers 42 QALY gained 42 fFN 42 treated nonsurgically 42 antitumor efficacy 42 Hematologic toxicity 42 aldosterone antagonist 42 titration regimen 42 refractive correction 42 pulmonary exacerbations 42 prescriber surveys 42 Personalised medicine 42 DSM IV diagnoses 42 thrombus aspiration 42 functional mitral regurgitation 42 histologic subtypes 42 carotid artery stenting CAS 42 mechanistic pathways 42 empathic responses 42 immunological mechanisms 42 suicide ideation 42 dichotomized 42 ACTEMRA TM 42 AF ablation procedures 42 2D 4D ratio 42 indicates cardio circulatory 42 immune reconstitution 42 cochlear implantation 42 cardiovascular calcification 42 EECP therapy 42 Nothing Wadden 42 preterm deliveries 42 spontaneous preterm delivery 42 chromium picolinate supplementation 42 carotid endarterectomy CEA 42 operable breast cancer 42 pulmonary artery banding 42 alexithymia 42 beta blocker therapy 42 unpaired t 42 meta analyzes 42 DNA methylation patterns 42 pretest probability 42 subscore 42 hepatic lesions 42 ADAS Cog 42 hemodynamic variables 42 pelvic lymphadenectomy 42 parthenogenetic embryonic stem cells 42 regression analyzes 42 severely immunosuppressed 41 Empirical evidence 41 Elevated triglycerides 41 immunomodulation 41 MDG5 41 Patient Outcomes 41 hemoglobin A1c 41 Holt Lunstad 41 euthymic patients 41 predictive 41 nonsurgical treatment 41 Achilles tendon ruptures 41 selenium supplementation 41 HEDIS R 41 Cardiopulmonary bypass 41 CHD coronary 41 neuropsychological deficits 41 chronic myocardial ischemia 41 acute subacute 41 RNFL thickness 41 undergoing coronary angiography 41 ICD implantations 41 nonpharmacologic interventions 41 shorter telomere length 41 metabolic dysregulation 41 psychometric properties 41 MTHFD1L gene 41 postoperative complications 41 socioeconomic inequalities 41 preoperative PSA 41 graft dysfunction 41 CIBIC + 41 MAOA genotype 41 obstetric interventions 41 symptomatic hyponatremia 41 Mechanistic studies 41 heritable diseases 41 MEDai Pinpoint Review 41 Antioxidant supplements 41 aldosterone antagonists 41 unmeasured confounders 41 ACCOMPLISH 41 somatic complaints 41 Vectibix monotherapy 41 warfarin dosage 41 hippocampal volume 41 gastrointestinal GI bleeding 41 monoclonal gammopathy 41 Health Assessment Questionnaire 41 Frederica Perera 41 neurocognitive outcomes 41 LV dysfunction 41 antiplatelet drugs 41 cyclic HMB 41 subtrochanteric 41 aneuploidy screening 41 endophenotypes 41 intelligence quotient IQ 41 genetic polymorphisms 41 cytoreductive surgery 41 levodopa induced 41 tic severity 41 dysrhythmias 41 HF ACTION 41 affective psychosis 41 Global Impression CGI 41 patientsâ € ™ 41 dysphoric 41 clinical meaningfulness 41 socioeconomic variables 41 Peter Pronovost 41 QOF 41 clopidogrel pretreatment 41 limiting generalizability 41 NSTE ACS 41 cardiac allograft vasculopathy 41 subconscious biases 41 DIABECELL ® 41 EXJADE 41 anticoagulation 41 carotid endarterectomy 41 MADRS score 41 lenalidomide dexamethasone 41 Randomized controlled 41 preventability 41 colorectal carcinogenesis 41 CMV reactivation 41 helping solve unsolvable 41 adjuvant tamoxifen 41 adenoma detection 41 T1DM 41 tumor recurrence 41 Genetic predisposition 41 transcatheter closure 41 Outcome Measurement 41 CYP#C# genotype 41 Swati Abbott 41 Socioeconomic factors 41 elevated triglyceride levels 41 oral antidiabetes drugs 41 casemix 41 conventional angiography 41 Beta coefficient 41 percutaneous vertebroplasty 41 longitudinal studies 41 morphometric vertebral fractures 41 multivessel disease 41 aromatase inhibitor therapy 41 subclinical cardiovascular disease 41 lipid lowering agents 41 diabetic polyneuropathy 41 chemoprevention trials 41 clinicopathologic 41 neurophysiologic 41 prelicensure 41 clinicopathological 41 malabsorptive 41 undertreatment 41 PANSS 41 KRAS mutation status 41 diagnosing ADHD 41 modifiable lifestyle 41 Clinical Outcomes 41 antiphospholipid antibodies 41 clinico pathological 41 ABSORB trial 41 intraoperative complications 41 randomized controlled trials 41 maternal neonatal 41 STEP BD 41 hemostatic efficacy 41 neonatal circumcision 41 eTag assays 41 APACHE II 41 efficacy endpoints 41 sequelae 41 POISE 41 tertile 41 routine episiotomy 41 Garcia Manero 41 OAB symptoms 41 Dr. Ziyad Hijazi 41 fibrosis progression 41 coronary artery revascularization 41 coinfected patients 41 monofocal 41 carotid revascularization 41 FeNO 41 ATIR ™ 41 endobronchial dysplasia 41 uncorrected visual acuity 41 cardiotoxic effects 41 sacral nerve stimulation 41 periprosthetic infection 41 neurologic sequelae 41 postnatally 41 postoperative delirium 41 CIPN 41 postpartum hemorrhage 41 physiologic responses 41 oral talactoferrin